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The survival of postmitotic neuronsneeds continuous degradation of cyclinB1, amitotic protein accumulated aberrantly in the damaged
brain areas ofAlzheimer’s disease and strokedpatients.Degradationof cyclinB1 takesplace in theproteasomeafter ubiquitylationby the
anaphase-promoting complex/cyclosome (APC/C)–cadherin 1 (Cdh1), an E3 ubiquitin ligase that is highly active in neurons. However,
during excitotoxic damage—a hallmark of neurological disorders—APC/C–Cdh1 is inactivated, causing cyclin B1 stabilization and
neuronal death through an unknownmechanism. Here, we show that an excitotoxic stimulus in rat cortical neurons in primary culture
promotes cyclin B1 accumulation in the mitochondria, in which it binds to, and activates, cyclin-dependent kinase-1 (Cdk1). The cyclin
B1–Cdk1 complex in the mitochondria phosphorylates the anti-apoptotic protein B-cell lymphoma extra-large (Bcl-xL), leading to its
dissociation from the  subunit of F1Fo–ATP synthase. The subsequent inhibition of ATP synthase activity causes complex I oxidative
damage, mitochondrial inner membrane depolarization, and apoptotic neuronal death. These results unveil a previously unrecognized
role for mitochondrial cyclin B1 in the oxidative damage associated with neurological disorders.
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Introduction
An increasing body of evidence indicates that the progressive
neuronal death associated with neurodegenerative diseases is a
consequence of a failed attempt of postmitotic neurons to aber-
rantly reenter the cell cycle (Herrup, 2013). Thus, in patients
suffering from Alzheimer’s disease (Vincent et al., 1997; Yang et
al., 2003) and stroke (Love, 2003), as well as in experimental
models of cerebral ischemia (Erdo¨ et al., 2004; Wen et al., 2004;
Rashidian et al., 2007), the affected brain areas aberrantly accu-
mulate cyclin B1. This is compatible with the notion that cyclin
B1 may be involved in the neuronal death associated with those
pathologies. In healthy neurons, cyclin B1 is degraded persis-
tently after ubiquitylation by the E3 ubiquitin ligase anaphase-
promoting complex/cyclosome (APC/C)– cadherin 1 (Cdh1;
Almeida et al., 2005). However, during excitotoxic damage—a
hallmark of neurological disorders (Bolan˜os et al., 2009; Wang
and Qin, 2010)—APC/C–Cdh1 is inactivated, causing aberrant
stabilization of cyclin B1 (Maestre et al., 2008), which mediates
neuronal death (Almeida et al., 2005; Maestre et al., 2008)
through a yet elusive molecular mechanism.
Excitotoxicity is one of the most common phenomena that
underlie the pathophysiology of neurological disorders (Wang
and Qin, 2010) and involves overactivation of glutamatergic re-
ceptors triggering massive Ca 2 entry into the postsynaptic
neuron. After an excitotoxic insult, mitochondria are thus over-
loaded of Ca 2, resulting in inner membrane potential (m)
disruption, which precedes neuronal apoptotic death (Bolan˜os et
al., 2009). Accordingly, keeping m intact represents an inter-
esting therapeutic strategy against neurodegeneration (Smith et
al., 2008). However, besides mitochondrial Ca 2 (Duchen,
2012), there are other yet unknown factor(s) responsible for the
m loss and neuronal death. Here, we show that, during an
excitotoxic stimulus, cyclin B1 is accumulated in the mitochon-
dria, accounting for the m loss and neuronal death. Further-
more, we found that this effect occurred through cyclin
B1-mediated activation of cyclin-dependent kinase-1 (Cdk1),
which phosphorylated B-cell lymphoma extra-large (Bcl-xL), re-
sulting in its dissociation from the  subunit of F1Fo–ATP syn-
thase. The subsequent inhibition in ATP synthase activity caused
increased mitochondrial superoxide anion (O2
) that damaged
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complex I, leading to them loss and bioenergetic crisis respon-
sible for apoptotic neuronal death.
Materials and Methods
Ethical statement regarding the use of animals. All animals (pregnant
Wistar female rats) used in this work were obtained from the Animal
Experimentation Service of the University of Salamanca, in accordance
with Spanish legislation (RD 1201/2005) under license from the Spanish
government. Protocols were approved by the Bioethics Committee of the
University of Salamanca.
Cell cultures. Primary cultures of rat cortical neurons were prepared
from fetal Wistar rats (of either sex) of 16 d of gestation (Maestre et al.,
2008), seeded at 2.5  10 5 cells/cm 2 in different-sized plastic plates
coated with poly-D-lysine (15 g/ml) and incubated in DMEM (Sigma-
Aldrich) supplemented with 10% fetal calf serum (FCS; Roche Diagnos-
tics). Cells were incubated at 37°C in a humidified 5% CO2-containing
atmosphere. At 48 h after plating, the medium was replaced with DMEM
supplemented with 5% horse serum (Sigma-Aldrich), 20 mM D-glucose,
and, on day 4, cytosine arabinoside (10 M) to prevent non-neuronal
proliferation. Cells were used for the experiments on day 6 –7 in vitro.
Human embryonic kidney-293T (HEK293T) cells were maintained in
DMEM supplemented with 10% (v/v) FCS. Twenty-four hours before
the experiment, cells were reseeded at 1.8  10 5 cells/cm 2 in plates
coated previously with poly-D-lysine (15 g/ml).
Plasmid constructions and site-directed mutagenesis. The following
plasmid constructions were used: (1) pIRES2–EGFP (Invitrogen), either
empty [control; expressing green fluorescent protein (GFP)] or contain-
ing the full-length cDNA of human Cyclin B1 (Cyclin B1; expressing
both cyclin B1 and GFP; Maestre et al., 2008); (2) pcDNA3–GFP (ex-
pressing GFP) or pcDNA3– cyclin B1–GFP, encoding human cyclin B1
fused to GFP (from J. Pines, Gurdon Institute, University of Cambridge,
Cambridge, UK; Almeida et al., 2005); (3) pSuper–neo.gfp (Oligoen-
gine), including the small hairpin sequences for luciferase (control;
5-CTGACGCGGAATACTTCGA-3) or cyclin B1 (shCyclin B1; 5-
GATGGAGCTGATCCAAACC-3; nucleotides 478 – 496, GenBank ac-
cession number AY338491; Almeida et al., 2005; Maestre et al., 2008); (4)
pMitoDsRed2 plasmid vector (MitoRed; Clontech), expressing red fluo-
rescent protein in mitocondria; and (5) p8 –Bcl-xL (from F. Pimentel,
Cancer Research Institute, University of Salamanca, Spanish National
Research Council, Salamanca, Spain) was subjected to site-directed mu-
tagenesis on Ser42, which was replaced by Ala or Asp residues to obtain the
phosphodefective [Bcl-xL(A); to block Cdk1 phosphorylation] and phos-
phomimetic [Bcl-xL(D)] forms of Bcl-xL (GenBank accession number
NM_138578.1), respectively, using the QuikChange XL kit (Stratagene), fol-
lowed by DpnI digestion. The forward and reverse oligonucleotides designed
were as follows, respectively: 5-TGGCACCTGGCAGACGCCCCCGCG-
GTGAATGGA-3 and 5-TCCATTCACCGCGGGGGCGTCTGCCAG-
GTGCCA-3 for Ser42Ala; and 5-TGGCACCTGGCAGACGACCCC-
GCGGTGAATGGA-3 and 5-TCCATTCACCGCGGGGTCGTCTGC-
CAGGTGCCA-3 for Ser42Asp.
Small interfering RNA. Specific depletion of Cdk5 was achieved by
using small (21 bp) interfering double-stranded ribonucleotides (siRNA)
designed specifically to target the coding sequence of the rat Cdk5 mRNA
(Maestre et al., 2008). We used the following siRNA (only the forward
strand shown): 5-AAGCCGUACCCGAUGUAUC-3 (nucleotides
859 – 877, GenBank accession number NM_080885). An siRNA against
luciferase (5-CUGACGCGGAAUACUUCGAUU-3) was used as con-
trol siRNA (siControl; Maestre et al., 2008). Annealed siRNAs were pur-
chased from Dharmacon (Abgene, Thermo Fisher Scientific).
Cell transfections and treatments. All transfections with plasmid con-
structions were performed using Lipofectamine 2000 (Invitrogen; Mae-
stre et al., 2008), following the instructions of the manufacturer. After
transfections, cells were incubated further for 4 –24 h until the experi-
ments and cell collection were performed. Transfections of neurons with
siRNAs were performed using Lipofectamine RNAiMAX (Invitrogen)
following the instructions of the manufacturer and used after 72 h.
To promote an excitotoxic insult, neurons were incubated with 100
M glutamate plus 10 M glycine in HBSS (in mM: 134.2 NaCl, 5.26 KCl,
0.43 KH2PO4, 4.09 NaHCO3, 0.33 Na2HPO4, 5.44 glucose, 20 HEPES,
and 4 CaCl2, pH 7.4) for 5 min and incubated further in culture medium
for the indicated time period (Almeida and Bolan˜os, 2001). When indi-
cated, incubations were performed in the presence of 100 ng/ml actino-
mycin D (ActD; Sigma), 1 g/ml cycloheximide (CHX; Sigma), 10 M
ProTAME (Boston Biochem, R&D Systems), and 1 mM glutathione ethyl
ester (GSH-EE; Sigma) or with 10 M roscovitine (Rosc; Sigma).
Subcellular fractionation. Cells were washed with cold PBS containing
1 mM MgCl2, harvested with cytosolic buffer (10 mM HEPES, 1.5 mM
MgCl2, 10 mM KCl, 1 mM EDTA, 0.1% NP-40, v/v, 1.5 M sucrose, and
protease and phosphatase inhibitors mixture, pH 7.9), triturated with a
micropipette to promote cell lysis, left on ice for 30 min, and vortexed for
10 s. After checking cell lysis under a light microscope, extracts were
centrifuged at 830 g for 10 min. Lysis of the nuclei was performed by
resuspending the nuclear pellet in nuclear buffer (50 mM HEPES, 1.5 mM
MgCl2, 10 mM KCl mM, 0.5 mM NaCl, 1 mM EDTA, 1% NP-40, v/v, and
protease and phosphatase inhibitor mixture, pH 7.9), triturated with a
micropipette, left on ice for 2 h, vortexed (10 s), boiled (5 min), and
sonicated (5 min). The supernatant (mitochondrial and cytosolic frac-
tions) was then centrifuged at 17,000  g for 12 min (4°C), and the
cytosolic fraction (supernatant) was lysed in 2 RIPA buffer (2% so-
dium dodecylsulphate, 2 mM EDTA, 2 mM EGTA, and 50 mM Tris, pH
7.5), supplemented with phosphatase inhibitors (1 mM Na3VO4 and 50
mM NaF) and protease inhibitors [100M phenylmethylsulfonyl fluoride
(PMSF), 50g/ml anti-papain, 50g/ml pepstatin, 50g/ml amastatin,
50 g/ml leupeptin, 50 g/ml bestatin, and 50 g/ml soybean trypsin
inhibitor], and boiled for 5 min (Maestre et al., 2008). The mitochondrial
fraction (pellet) was resuspended in isolation medium (in mM: 320 su-
crose, 1 potassium EDTA, and 10 Tris-HCl, pH 7.4) and was homoge-
nized in a tight-fitting glass–Teflon homogenizer (20 strokes; Almeida
and Medina, 1998). Mitochondrial fraction was either lysed with 2
RIPA buffer for protein analysis by immunoblotting or used for the
identification of intramitochondrial localization of cyclin B1, as de-
scribed below.
Mitochondrial fraction was incubated in buffer (in mm: 1 EDTA
and 10 MOPS-KOH, pH 7.2) containing 320 or 70 mM sucrose on ice
for 30 min and was centrifuged at 16,000 g at 4°C for 10 min. Pellets
were resuspended in RIPA buffer, and all fractions were analyzed by
immunoblotting.
The protease protection assay (Wang et al., 2014 1) was performed
by incubating mitochondrial fraction in buffer (in mM: 1 EDTA, 10
MOPS-KOH, and 320 sucrose, pH 7.2) on ice for 30 min with or
without 25 or 50 g/ml trypsin. Proteolysis was stopped by addition
of 1 mM PMSF, and samples were centrifuged 16,000 g at 4°C for 10
min. Pellet were resuspended in RIPA buffer, and proteins were ana-
lyzed by immunoblotting.
Western blot. Cells were lysed in 2% sodium dodecylsulphate, 2 mM
EDTA, 2 mM EGTA, and 50 mM Tris, pH 7.5, supplemented with phos-
phatase inhibitors (1 mM Na3VO4, 50 mM NaF) and protease inhibitors
(100M phenylmethylsulfonyl fluoride, 50g/ml anti-papain, 50g/ml
pepstatin, 50 g/ml amastatin, 50 g/ml leupeptin, 50 g/ml bestatin,
and 50 g/ml soybean trypsin inhibitor), stored on ice for 30 min, and
boiled for 10 min. Aliquots of cell extracts were subjected to SDS poly-
acrylamide gel (MiniProtean; Bio-Rad) and blotted with primary anti-
bodies at dilutions ranging from 1:200 to 1:1000 overnight at 4°C.
Antibodies used were anti-cyclin B1 (BD Biosciences Pharmingen), anti-
Cdk1 (Santa Cruz Biotechnology) anti-voltage-dependent anion chan-
nel (VDAC; Merck Millipore), anti-proliferating cell nuclear antigen
(BD Biosciences Pharmingen), anti-GAPDH (Ambion), anti-Bcl-xL (BD
Biosciences), anti-phosphoserine (Zymed, Invitrogen), anti--ATPase
(Abcam), anti-Hsp60 (Abcam), anti-translocase of the outer mitochon-
drial membrane 20 (TOM20; Abcam), and anti-Ndusf1 [NADH dehy-
drogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH– coenzyme Q
reductase); Santa Cruz Biotechnology]. After incubation with horse-
radish peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz Bio-
technology) or goat anti-mouse IgG (1:10,000 dilution; Santa Cruz
Biotechnology), membranes were incubated immediately with the en-
hanced chemiluminescence kit SuperSignal West Dura (Pierce, Thermo
Fisher Scientific) for 5 min or Immobilon Western Chemiluminiscent
HRP Substrate (Merck Millipore) for 1 min, before exposure to Kodak
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XAR-5 film for 1–5 min, and the autoradiograms were scanned. Biolog-
ically independent replicates (three to four different independent cell
cultures) were always performed, and a representative Western blot is
shown. The protein abundances were measured by densitometry of the
bands on the films using NIH ImageJ version 1.48u4 software and were
normalized against the corresponding loading control.
RT-PCR. Total RNA was purified from neurons using a commercially
availablekit(Sigma).CyclinB1andGAPDHmRNAexpressionwasanalyzedby
3% agarose electrophoresis after RT-PCR using the following forward and
reverse oligonucleotides, respectively: 5-CAACTGGAGGAAGAGCAGTCA-
3and 5-CATCTGAACCTGTATTAGCCA-3 for Cyclin B1; and 5- GGGT-
GTGAACCACGAGAAAT-3 and 5- GACTGTGGTCATGAGCCCTT-3 for
GAPDH. RT was performed at 48°C for 50 min, and PCR conditions were 10
min at 95°C, 35 cycles of 30 s at 95°C, 30 s at 52°C, and 1 min at 72°C. Final
extension was performed for 10 min at 72°C. In no case was a band detected by
PCR without RT.
Cdk1 kinase assay.Cells were lysed in ice-cold buffer containing 50 mM
Tris, pH 7.5, 150 mM NaCl, 2 mM EDTA, and 1% NP-40, supplemented
with the phosphatase and protease inhibitors cited above. After clearing
debris by centrifugation, extracts (200 g protein) were incubated with
anti-Cdk1 (2 g) for 4 h at 4°C, followed by the addition of 30 l of
protein A-Sepharose (GE Healthcare) for 2 h at 4°C. Immunoprecipi-
tates were washed four times in lysis buffer and resuspended in kinase
buffer (in mM: 50 HEPES, pH 7.5, 10 MgCl2, 1 EDTA, and 0.1 dithiothre-
itol) containing 20 M ATP, 2 Ci of [- 32P]ATP, and histone H1 (1
mg/ml; Sigma-Aldrich). Samples were subjected to SDS-PAGE (12%),
and transferred proteins were visualized by autoradiography or blotted
with anti-Cdk1.
Coimmunoprecipitation assay. Cells were lysed in ice-cold buffer con-
taining 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, and 1%
NP-40, supplemented with the phosphatase and protease inhibitors cited
in Western blot analysis. Cell extracts were clarified by centrifugation,
and supernatants (500 g of protein) were incubated with 2 g of anti-
Bcl-xL for 4 h at 4°C, followed by the addition of 30 l of protein
A-Sepharose (GE Healthcare) for 2 h at 4°C. Immunoprecipitates were
washed extensively with lysis buffer and detected by Western blot analysis
(Gomez-Sanchez et al., 2011).
Isolation of mitochondria. Mitochondrial fractions were isolated as de-
scribed by Almeida and Medina (1998), which provides a rapid method
for isolation of intact functional mitochondria from cultured cells. In
brief, cells were washed twice with cold PBS and collected in isolation
medium (in mM: 320 sucrose, 1 potassium EDTA, and 10 Tris-HCl, pH
7.4), centrifuged at 600 g for 5 min (4°C), and resuspended in isolation
medium. Cells were homogenized in a tight-fitting glass–Teflon homog-
enizer (20 strokes), and the nuclei and lysed membranes were removed
by centrifugation at 1500 g for 10 min (4°C). We then centrifuged the
supernatant at 17,000  g for 11 min (4°C), and pellet (mitochondrial
fraction) was suspended in isolation buffer. The supernatant contained
the cytosolic fraction.
Blue native PAGE and immunoblotting for oxidized protein detection.
Isolated mitochondria (0.5 mg of protein) were treated with 50 mM
N-ethylmaleimide (NEM) for 10 min at 37°C, pelleted, and washed with
isolation medium (in mM: 320 sucrose, 1 potassium EDTA, and 10 Tris-HCl,
pH 7.4). Then, mitochondria were treated with 2 mM dithiothreitol for 10
min and washed with isolation medium. After treating mitochondria with 25
mM iodoacetyl-LC-biotin for 10 min in the dark, mitochondria were incu-
bated in ice-cold digitonin buffer [1% (w/v) digitonin, 1 M 6-aminohexanoic
acid, and 50 mM Bis-Tris HCl, pH 7.0] for 5 min in ice. After centrifuga-
tion for 30 min at 13,000 g, the supernatant was collected, and 5% (v/v)
Coomassie Brilliant Blue G-250 in 1 M 6-aminohexanoic acid was added
to the supernatant. Samples were resolved on a 1-mm-thick 3–12% poly-
acrylamide gradient gel. Gel was dyed with a nitroblue tetrazolium test to
remark the situation of complex I, and the band was excised with a razor
blade and incubated for 5 min at room temperature in 125 mM Tris-HCl,
pH 7.0, containing 1% SDS and 50 mM NEM before insertion over the
1.5-mm-thick SDS–polyacrylamide gel. Stacking gel was polymerized
around the excised bands, and proteins were separated by electrophoresis
in a MiniProtean system (Bio-Rad). Oxidized proteins were detected
after blotting onto nitrocellulose membranes with streptavidin– horse-
radish peroxidase conjugate (1:1000; Thermo Fisher Scientific) to visu-
alize biotinylated reagents. Signal detection was performed with an
enhanced chemiluminescence kit (Hurd et al., 2008).
Determination of mitochondrial enzyme activities. Cells were collected
by trypsinization, centrifuged, and resuspended in 300l of 0.1 M potas-
sium phosphate buffer, pH 7.0. Samples were freeze–thawed three times
to ensure cellular disruption. Enzyme activities were measured in cell
lysates (80 –100 g of protein) at 30°C using a Kontron spectrophotom-
eter (Uvikon XL; NorthStar Scientific). Nicotinamide adenine dinucle-
otide (NADH)–CoQ1 reductase (complex I) activity was measured as the
rotenone-sensitive rate of NADH oxidation (at 340 nm; Ragan et al.,
1987). Cell lysates was incubated in 25 mM potassium phosphate, pH 7.2,
containing 0.2 mM NADH, 10 mM MgCl2, 1 mM KCN, and 2.5 mg of
fat-free bovine serum albumin (BSA), and the reaction was initiated with
50 M ubiquinone-1. For measurement of the rotenone-insensitive
NADH oxidation activity, the assay was also performed in the presence of
10 M rotenone.
Succinate– cytochrome c reductase (complex II–III) activity was mea-
sured as the antimycin A-sensitive rate of cytochrome c reduction (at 550
nm; King, 1967). The reaction mixture contained 100 mM potassium
phosphate, pH 7.4, 0.3 mM EDTA, 1 mM KCN, and 0.1 mM cytochrome c
and was initiated with 20 mM succinate. The assay was also performed in
the presence of 20 g/ml antimycin A to determine the actimycin
A-insensitive complex II–III activity.
Cytochome c oxidase (complex IV) was measured as the rate of cyto-
chrome c oxidation (at 550 nm; Wharton and Tzagoloff, 1967). The test
cuvette contained 10 mM potassium phosphate, pH 7.0, and 50 M re-
duced cytochrome c. The reference cuvette also contained 1 mM
K3Fe(CN)6. The reaction was initiated by adding cell lysate to the test
cuvette, and the first-order velocity constant (k) was calculated.
The ATPase activity was measured in a linked enzyme system as the
oligomycin-sensitive rate of NADH oxidation (at 340 nm), using the
method of Soper and Pedersen (1979). The oxidation of NADH to
NAD results from a coupled reaction catalyzed by pyruvate kinase and
lactate dehydrogenase in the presence of phosphoenolpyruvate, depen-
dent on ADP production by the ATPase in the presence of ATP. The
reaction mixture contained 50 mM Tris-HCl, pH 8.0, 5 mM phosphoe-
nolpyruvate, 2 mM KCN, 0.3 mM NADH, 100 mM HCl, 6 mM MgCl2, 10
M rotenone, 25 U/ml lactate dehydrogenase, 25 U/ml pyruvate kinase,
and 6 mM ATP. The rate inhibited by the addition of 5g/ml olygomycin
was taken to be the ATPase activity.
Citrate synthase activity was measured as in the study by Shepherd and
Garland (1966) (at 412 nm) . Cell lysates were incubated in 100 mM
Tris-HCl, pH 8.0, 0.1 mM acetyl-CoA, 0.2 mM 5,5-dithiobis(2-
nitrobenzoic acid), 0.1% (v/v) Triton X-100, and 200 M oxaloacetate.
All enzyme activities were expressed as nanomoles per minute per
milligram of protein, except for cytochrome c oxidase, which was ex-
pressed as the first-order rate constant (k) per minute per milligram of
protein.
Oxygen consumption assay.Cells were removed from the flasks by mild
trypsinization. The rate of oxygen consumption was measured in 10 6
cells suspended in HBSS (containing 5.5 mM glucose) at 30°C, using a
Clark-type dissolved oxygen electrode (Digital model 20; Rank Broth-
ers). Results are expressed as nanomoles of O2 consumed per minute per
10 6 cells (Almeida et al., 2001).
Immunocytochemistry. Neurons grown on glass coverslips were fixed
with 4% (v/v, in PBS) paraformaldehyde for 30 min and immunostained
with mouse anti-Cyclin B1 (1:100) and rabbit anti-Bcl-xL (1:100; BD
Biosciences) antibodies (Gomez-Sanchez et al., 2011). Immunolabeling
was detected using anti-mouse IgG–Cy3 (1:500) or anti-rabbit IgG–Cy5
(1:500; Jackson ImmunoResearch). Coverslips were washed, mounted in
SlowFade light antifade reagent (Invitrogen) on glass slides, and exam-
ined using a scanning laser confocal microscope (TSC SL; Leica) with
three lasers [multiline argon (458, 488 nm), green helium–neon (543
nm), and red helium–neon (633 nm)] and equipped with 40, 63 (1.4
numerical aperture) HCX PL Apo oil-immersion objectives for high-
resolution imaging.
Flow cytometric detection of apoptotic cell death.Neurons were detached
carefully from the plates using 1 mM EDTA (tetrasodium salt) in PBS, pH
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7.4, and were stained with annexin V–adenomatous polyposis coli (APC)
and 7-aminoactinomycin D (7-AAD) in binding buffer (in mM: 100
HEPES, 140 NaCl, and 2.5 CaCl2) to determine quantitatively the per-
centage of apoptotic neurons by flow cytometry. Cells were stained with
annexin V–APC and 7-AAD in binding buffer (in mM: 100 HEPES, 140
NaCl, and 2.5 CaCl2), according to the instructions of the manufacturer,
and 3  10 5 cells were analyzed, in four replicates per condition, on a
FACScalibur flow cytometer (15 mW argon ion laser tuned at 488 nm;
CellQuest software; BD Biosciences). Transfected (identified by GFP flu-
orescence) cell populations were analyzed, and the annexin V–APC-
stained cells that were 7-AAD-negative were considered to be apoptotic
(Gomez-Sanchez et al., 2011).
Flow cytometric detection of active caspase-3. Active caspase-3 was de-
tected in the GFP-expressing (GFP) neurons using the ApoActive3 kit
(Bachem). After detaching cells with 1 mM EDTA (tetrasodium salt) and
centrifuging, cell pellets were fixed during 20 min, resuspended in PBS
plus 2% BSA, and incubated for 1 h with 1 rabbit anti-caspase 3. Cells
were then incubated with 1:500 anti-rabbit Cy3 (Jackson ImmunoRe-
search) for 1 h. Between each step, cells were washed with either PBS
(until labeling of samples) or PBS plus 1% BSA and resuspended in PBS
plus 1% BSA before analysis by flow cytometry (tuned at 488 nm; Cell-
Quest software; BD Biosciences).
Flow cytometric detection of m and mitochondrial superoxide genera-
tion. m was assessed using the MitoProbe DilC1(5) Assay Kit for Flow
Cytometry (Invitrogen), and stained cells were analyzed on the FL1 and
FL4 channels of a FACScalibur flow cytometer (15 mW argon ion laser
tuned at 488 nm; CellQuest software; BD Biosciences). m values were
expressed as percentages, using carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone (10 M) to define the 0% m values. Mitochondrial
superoxide production was assessed using the fluorescent MitoSox probe
(Invitrogen) by flow cytometry, as described previously (Quintana-
Cabrera et al., 2012).
Protein determinations.Protein concentrations were determined in the
cell suspensions, lysates, or in parallel cell culture incubations after sol-
ubilization with 0.1 M NaOH. Protein concentrations were determined as
described previously (Lowry et al., 1951), using BSA as standard.
Statistical analysis.All measurements in cell culture were performed, at
least, in triplicate, and the results are expressed as the mean SEM values
from at least three different culture preparations. For the comparisons
between two groups of values, the statistical analysis of the results was
performed by the Student’s t test. For multiple values comparisons, we
used one-way ANOVA, followed by Bonferroni’s test. The statistical
analysis was performed using the SPSS 16.0 software for Macintosh. In all
cases, p 0.05 was considered significant.
Results
Cyclin B1–Cdk1 activity mediates neuronal apoptotic death
via the mitochondrial pathway on an excitotoxic stimulus
To investigate the molecular mechanism responsible for cyclin
B1-mediated neurodegeneration, neurons were incubated with
100 M glutamate for 5 min, followed by harvesting at different
time points, a previously validated excitotoxic stimulus known to
cause cyclin B1 stabilization (Maestre et al., 2008). As shown in
Figure 1A, glutamate triggered a time-dependent accumulation
of endogenous cyclin B1 in whole-cell extracts, confirming our
previous findings (Maestre et al., 2008).
Cyclin B1 mRNA was unaltered (Fig. 1B), and its protein ac-
cumulation was not prevented by the transcription inhibitor
ActD and the protein synthesis inhibitor CHX (Fig. 1C), indicat-
ing that glutamate induced cyclin B1 protein stabilization by a
posttranslational mechanism. We reported that APC/C–Cdh1
activity destabilizes cyclin B1 protein as an essential survival
mechanism for neurons (Almeida et al., 2005). Moreover, exci-
totoxic stimulus inactivates APC/C–Cdh1, causing aberrant cy-
clin B1 stabilization that leads to apoptotic neuronal death
(Maestre et al., 2008). Here, we show that the APC/C inhibitor
ProTAME mimicked glutamate-induced cyclin B1 accumulation
(Fig. 1D). In accordance with the finding that the inactivation of
APC/C–Cdh1 during excitotoxicity requires Cdk5 (Maestre et al.,
2008), this protein was knocked down by RNA interference using
a previously validated siRNA against Cdk5 (siCdk5; Maestre et
al., 2008), which resulted in the abolishment of glutamate-
induced cyclin B1 accumulation (Fig. 1E). Altogether, these re-
sults confirm our previous findings (Maestre et al., 2008) that an
excitotoxic stimulus activates Cdk5, which inhibits APC/C, lead-
ing to aberrant cyclin B1 accumulation.
During the excitotoxic insult, the increase in cyclin B1 protein
paralleled that of Cdk1 activity, as assessed by its ability to phos-
phorylate histone H1 (Fig. 1F), suggesting functional activation
of the cyclin B1–Cdk1 complex. Furthermore, such Cdk1 activa-
tion was abolished by siRNA-mediated knockdown of Cdk5 (Fig.
1F), confirming the involvement of Cdk5 in this process. To
assess whether the cyclin B1–Cdk1 complex was responsible for
neuronal death after the excitotoxic stimulus, we next knocked
down cyclin B1 using a previously validated shRNA (shCyclin B1;
Almeida et al., 2005) or inhibited Cdk(s) with Rosc. As shown in
Figure 1G, both treatments mostly attenuated the time-
dependent neuronal apoptotic death triggered by glutamate.
Conversely, ectopic expression of cyclin B1 triggered a time-
dependent increase in apoptotic neuronal death (Fig. 2A) and
loss of cyclin B1-containing (GFP) neurons (Fig. 2B) that
reached the statistical significance after 18 h of transfection. Ax-
onal disruption, characteristic of apoptotic death, was also ob-
served by epifluorescence after 24 h of the ectopic expression of a
cyclin B1 (Fig. 2B). Moreover, active caspase-3 was increased in
cyclin B1-expressing neurons as assessed by flow cytometry (Fig.
2C), confirming apoptotic death. Cyclin B1-mediated apoptotic
death was abolished by the caspase inhibitors zVAD-fmk and
zDEVD-fmk, as well as by the caspase-3-specific inhibitor
zDQMD-fmk (Fig. 2D). However, inhibiting caspase-8 with
zIETD-fmk or caspase-2 with zVDVAD-fmk failed to prevent
cyclin B1-mediated apoptotic death (Fig. 2D), ruling out the
non-mitochondrial apoptotic pathway in the process. In con-
trast, inhibition of mitochondrial-dependent caspase-9 with
zLEHD-fmk fully prevented cyclin B1-mediated apoptotic death
(Fig. 2D). Thus, cyclin B1 induces neuronal apoptotic death
via the intrinsic mitochondrial pathway through caspase-3/
caspase-9 activation.
Cyclin B1–Cdk1 accumulates in mitochondria on the
excitotoxic stimulus, leading to oxidative stress and energy
deficiency
In view of the evidence for a mitochondrial involvement in cyclin
B1-mediated neuronal apoptotic death, we next sought to inves-
tigate whether cyclin B1, and its catalytic partner Cdk1, occurred
in this organelle. Interestingly, glutamate treatment promoted
the accumulation of endogenous cyclin B1 and Cdk1 in mito-
chondria purified from neurons, as revealed by Western blotting
(Fig. 3A). This was confirmed in HEK293T cells transfected with
the full-length cDNA encoding cyclin B1 (Fig. 3B).
To further corroborate the occurrence of cyclin B1 in
mitochondria, neurons were cotransfected with MitoRed—
which delivers the red fluorescent protein specifically into mito-
chondria—and cyclin B1–GFP (or GFP alone as control) cDNA
constructs. Confocal images showed that MitoRed fluorescence
colocalized with that of GFP in neurons transfected with the cy-
clin B1–GFP fusion cDNA (cyclin B1 neurons) but not with those
transfected with GFP alone (control neurons; Fig. 3C). Thus, the
accumulation of cyclin B1 protein during either glutamate treat-
ment or exogenous cyclin B1 expression occurs primarily in mi-
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tochondria. Because glutamate-mediated excitotoxicity is known
to increase mitochondrial superoxide (O2
) production and in-
ner membrane depolarization, we next investigated the possible
involvement of mitochondrial cyclin B1 in these phenomena. As
shown in Figure 3D, mitochondrial O2
 time dependently in-
creased from 4 h after the excitotoxic stimulus, an effect that was
mostly attenuated but not abolished, by knocking down cyclin B1
with shCyclin B1, or by inhibiting Cdk1 with Rosc. Moreover,
Figure 1. Cyclin B1–Cdk1 activitymediates neuronal apoptotic death on an excitotoxic stimulus. Rat cortical neuronswere treatedwith glutamate (100M, 5min) andwere further incubated in culture
medium for 1–20h.A,Westernblots of neuronal extractswereprobed sequentiallywith antibodies to cyclinB1andCdk1, followedbyGAPDHas loading control.B, CyclinB1andGAPDHmRNAexpressionwas
analyzedby3%agaroseelectrophoresis afterRT-PCR.GAPDH isahousekeepinggeneandusedas loadingcontrol inPCR.One representativegel is shownof three. Shown is the relative cyclinB1mRNA levels, as
normalizedwithGAPDH, averaged from three independent neuronal cultures (n	3). After glutamate stimulation (100M, 5min), neuronswere incubated in culturemediumcontaining the transcriptional
inhibitor ActD (100 ng/ml), the protein synthesis inhibitor CHX (1g/ml), or the APC/C inhibitor ProTAME (10M) for 20 h. C, Treatment with ActD or CHX did not prevent glutamate-induced cyclin B1
accumulation in neurons.D, ProTAME promoted neuronal cyclin B1 stabilization. E, Neurons on day 4 in vitrowere transfectedwith an siRNA against luciferase (siControl; 100 nM) or with siRNA against Cdk5
(siCdk5;100nM)for3d.KnockdownofCdk5(siCdk5-treatedneurons)preventedcyclinB1accumulationinglutamate-treatedneurons. InA,C,D,andE,arepresentativeWesternblot isshownofthree.Bargraphs
represent the relative cyclin B1 protein abundance, as normalizedwith GAPDH, averaged from at least three independent neuronal cultures. In all cases, the represented values aremeans SEM (n	 3–4
independent neuronal cultures). *p 0.05 versus untreated (Glu) neurons. F, Glutamate triggered a time-dependent stimulation of Cdk1 activity, as assessed by the ability of the protein extracts to
phosphorylate, in vitro, histone H1. Transfection with siCdk5 abrogated glutamate-caused Cdk1 activation. Each bar represents the mean SEM of three independent neuronal cultures. *p 0.05 versus
siControl 0h.G,Neuronsonday4 in vitrowere transfectedwithanshRNAagainst luciferase (Control) orwithanshRNAagainst cyclinB1 (shCyclinB1) for2d. Then,neuronswere incubated (ornot in theControl
condition) with glutamate (100M, 5min; Glutamate condition) after incubationwith culturemedium for the indicated time points. When indicated, Rosc (10M) was added to the culturemedium. Both
shCyclinB1andRoscabrogatedneuronalapoptoticdeathcausedbyglutamatebutdidnotmodifyapoptosis incontrol (untreated)neurons(20h:shCyclinB1,13.520.89%;Rosc,12.770.79%),asassessed
by annexin V/7-AAD quantification by flow cytometry. Representative flow cytometric dot plots are shownof four independent experiments. Data are themean SEM from four independent neuronal
cultures (n	 4). *p 0.05 versus control; #p 0.05 versus glutamate. AD, ActinomycinD;MW,molecularweight.
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glutamate time dependently decreased m, which was pre-
vented partially by shCyclin B1 or Rosc (Fig. 3E), mirroring the
effects on mitochondrial O2
 (Fig. 3D). Interestingly, incubation
of neurons with the free radical scavenger GSH-EE nearly abol-
ished glutamate-induced m collapse (Fig. 3E), suggesting that
increased O2
 preceded m loss. Likewise, the ectopic expres-
sion of cyclin B1 mimicked glutamate treatment, because neu-
rons displayed a time-dependent increase in O2
 (Fig. 3F) and
m loss (Fig. 3G). Furthermore, these effects were rescued com-
pletely by either Rosc (Fig. 3F) or GSH-EE (Fig. 3G). Thus, our
time course study shows that m loss precedes apoptotic death
on the excitotoxic stimulus, indicating that mitochondrial dys-
function is a cause, not a consequence, of the neuronal apoptotic
process, thus confirming the importance form maintenance in
neuronal survival (White and Reynolds, 1996; Almeida and Bo-
lan˜os, 2001). Because m loss on excitotoxic damage is often
associated with energy depletion, we determined the concentra-
tion of neuronal ATP, which was decreased (Fig. 3H); this effect
was prevented partially by Rosc, indicating the contribution of
Cdk activity in energy depletion. Thus, glutamate-mediated cy-
clin B1–Cdk1 activation in mitochondria induces oxidative
stress, leading to mitochondrial dysfunction and energy
deficiency.
Cyclin B1–Cdk1 activation inhibits ATP synthase, leading to
oxidative damage to complex I
Next, we aimed to understand the molecular mechanism responsi-
ble for mitochondrial dysfunction by cyclin B1–Cdk1 activity. To do
so, we first analyzed the mitochondrial respiratory chain in
HEK293T cells transfected with the full-length cDNA encoding cy-
clin B1. As expected, cyclin B1 protein levels time dependently in-
creased in the transfected cells (Fig. 4A). As shown in Figure 4B,
Figure 2. Cyclin B1 induces neuronal apoptotic death via the intrinsic mitochondrial pathway activation. A, Rat cortical neurons were transfected with 0.8g/10 6 cells pIRES2–EGFP, either
empty (Control; expressing GFP) or containing the full-length cDNA of human cyclin B1 (Cyclin B1; expressing both cyclin B1 and GFP) for 6–24 h. cyclin B1 expression time dependently induced
neuronal apoptotic death, as assessed by annexin V/7-AAD quantification by flow cytometry. *p 0.05 versus control. B, Epifluorescence microphotographs revealed the typical axonal
disruption of apoptosis in cyclin B1-transfected neurons (24 h). Scale bar, 50m. Transfection rate (percentage of GFP neurons) was determined by flow cytometry. *p 0.05 versus control. C,
Cyclin B1 induced caspase 3 cleavage and activation by 24 h after transfection of neurons, as showed by quantitative analyses of GFP (transfected) neurons by flow cytometry. *p 0.05 versus
control.D, Rosc (10M)or caspase inhibitors (zVAD-fmkandzDEVD-fmk; 100M)prevented cyclinB1-mediatedneuronal deathat 24hof transfection. Inhibitionof caspases-8 (zIETD-fmk; 100M)
or caspase-2 (zVDVAD-fmk, 100M)was ineffective. Caspase-3 (zDQMD-fmk; 100M) or caspase-9 inhibition (zLEHD-fmk; 50M) abrogated cyclin B1-mediated neuronal death. *p 0.05 versus
control. In all cases, data are the mean SEM of four independent neuronal cultures (n	 4).
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Figure 3. cyclin B1–Cdk1 accumulates in mitochondria on the excitotoxic stimulus, leading to oxidative stress and energy deficiency. A, Neurons were treated with 100M glutamate for 5min
and were further incubated in culture medium for 20 h. Western blots of nuclear (Nuclei), mitochondrial (Mito), and cytosolic (Cyto) extracts were probed sequentially with antibodies to cyclin B1
and Cdk1, followed by VDAC asmitochondrial marker, Lamin B as nuclearmarker, and GAPDH as cytosolic marker. A representativeWestern blot is shown of three. Bar graphs represent the relative
cyclin B1 protein abundance compared with the cytosolic fraction from untreated (Glu) cells. Each bar represents the mean SEM of three independent neuronal cultures (n	 3). *p 0.05
versus untreated neurons.B, HEK293T cells were transfectedwith 0.8g/10 6 cells pIRES2–EGFP, either empty (expressing GFP) or containing the full-length cDNA of human Cyclin B1 (expressing
both cyclin B1 andGFP) for 24 h.Western blotwere performedas inA. Bar graphs represent the relative cyclin B1protein abundance comparedwith cytosolic fraction fromcontrol (Cyclin B1) cells.
Each bar represents themean SEM of three independent cell cultures (n	 3). *p 0.05 versus control cells. C, Neuronswere cotransfectedwith plasmid encoding either GFP (0.8m/10 6 cells
pcDNA3–GFP; control) or cyclin B1 fused with GFP (0.8m/10 6 cells pcDNA3– cyclin B1-GFP; cyclin B1-GFP) and themitochondrial marker MitoRed (0.8m/10 6 cells pMitoDsRed2) for 12–14 h.
Microphotograph reveals colocalization of cyclin B1–GFP, but not GFP (control), withMitoRed in neurons. Neuronswere immunostainedwith the neuronalmarkerMap2 (violet). Scale bar, 50m.
D, Neurons on day 4 in vitrowere transfectedwith an shRNA against luciferase (Control) or with an shRNA against cyclin B1 (shCyclin B1) for 2 d. Then, neuronswere treatedwith 100M glutamate
for 5 min and were further incubated in culture medium for 4–20 h. When indicated, Rosc (10M) was added to the culture medium. Glutamate time dependently induced mitochondrial O2

generation in neurons. Both shCyclin B1 and Rosc partially abrogated glutamate-caused mitochondrial O2
 generation in neurons but did not modify values in control (untreated) neurons (20 h:
shCyclin B1, 10.39 0.67%; Rosc, 9.33 0.54%). *p 0.05 versus control; #p 0.05 versus glutamate. E, Neurons were transfected and treated as in D. Glutamate time dependently induced
mitochondrial depolarization in neurons. Treatmentwith shCyclin B1, Rosc (10M), and GSH-EE (1mM) prevented glutamate-causedm collapse in neurons. However, these treatments did not
modify values in control (untreated) neurons (20 h: shCyclin B1, 105.4 8.79%; Rosc, 109.3 9.25%; GSH-EE, 112.7 7.74). *p 0.05 versus control; #p 0.05 versus glutamate. F, Neurons
were transfectedwith 0.8g/10 6 cells pIRES2–EGFP, either empty (Control; expressing GFP) or containing the full-length cDNA of human cyclin B1 (Cyclin B1; expressing (Figure legend continues)
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cyclin B1 induced a time-dependent inhibition in mitochondrial
complex I activity; however, complexes II–III and IV were unaf-
fected (complex II–III: control, 2.73  0.11 nmol  min1  mg1
protein; cyclin B1, 2.60 0.13 nmol  min1  mg1 protein; com-
plex IV: 0.33 0.03, 0.27 0.03 k  min1  mg1 protein; citrate
synthase: control, 135 10.3; cyclin B1, 141 11.9). Interestingly,
we also found that ATP synthase activity was decreased on cyclin
B1 expression (Fig. 3C). Notably, inhibition of ATP synthase
activity by cyclin B1 preceded (12 h; Fig. 3C) that of complex I (18
h; Fig. 3B). In view of the inhibitory effect of cyclin B1 on complex
I, we sought to investigate whether the mitochondrial respiration
was impaired. As shown in Figure 4D, the rate of O2 consumption
showed a biphasic effect on cyclin B1 expression, being increased
at 12 h and decreased at 24 h. It is noteworthy that the increase in
O2 respiration (12 h; Fig. 4D) occurs at a time point in which
complex I was unaffected (Fig. 4B) and ATP synthase was inhib-
ited (Fig. 4C). In view of this intriguing phenomenon, we were
prompted to investigate the mechanism responsible for this
effect.
Because ATP synthase inhibition is known to induce transient
mitochondrial inner membrane hyperpolarization (Brand et al.,
2004; Sa´nchez-Cenizo et al., 2010; Formentini et al., 2014), we
next assessed m in cells expressing cyclin B1. As shown in
Figure 4E, m increased at 12 h, and it was followed by a de-
crease at 24 h of transfection, thus mimicking the same time-
dependent changes of cell O2 consumption (Fig. 4D). Thus, it is
tempting to suggest that cyclin B1 primarily inhibited ATP syn-
thase, leading to increased mitochondrial O2 consumption, m
and O2
, which secondarily will lead to damage to complex I. In
fact, increased m enhances mitochondrial O2
 generation
(Brand et al., 2004; Sa´nchez-Cenizo et al., 2010; Formentini et al.,
2014), and, in neurons, cyclin B1 increased m (although it did
not reach statistical significance; Fig. 3G) and mitochondrial O2

(Fig. 3F). Moreover, because mitochondrial O2
 causes primarily
complex I oxidative damage (Bolan˜os et al., 2009), we then as-
sessed whether cyclin B1–Cdk1 activity causes oxidative damage
to complex. As shown in Figure 4F, cyclin B1 induced complex I
oxidation, as judged by the increase in oxidized proteins detected
by immunoblotting from isolated biotin–NEM-labeled mito-
chondrial complex I subunits. Complex I oxidation was pre-
vented by GSH-EE (Fig. 4F) and Rosc (Fig. 4F). Furthermore,
complex I inhibition caused by cyclin B1 expression in HEK293T
cells was rescued by Rosc and GSH-EE (Fig. 4G). These results
strongly suggest complex I oxidative damage by cyclin B1–Cdk1
activity. Moreover, ATP synthase inhibition caused by cyclin B1
expression in HEK293T cells was rescued by Rosc but not by
GSH-EE, suggesting that cyclin B1–Cdk1-mediated inhibition of
ATP synthase was not oxidative (Fig. 4H). Thus, we propose that
the sequence of events occurring by cyclin B1–Cdk1 activation
first starts by inhibiting ATP synthase, which leads to enhanced
O2 consumption and m, which stimulates O2
. Such an in-
crease in O2
 causes complex I oxidative damage, leading to the
delayed impairment of cell O2 consumption.
Cyclin B1–Cdk1 phosphorylates Bcl-xL, leading to its
dissociation from-F1Fo–ATP synthase and causing ATP
synthase and complex I inhibition on the excitotoxic stimulus
We next sought to investigate the molecular mechanism whereby
cyclin B1–Cdk1 inhibited ATP synthase. According to a recent
study, the enzymatic activity of ATP synthase can be activated by
direct interaction of its -subunit with Bcl-xL in neurons (Ala-
vian et al., 2011). Conversely, in tumor cells, cyclin B1–Cdk1
phosphorylates and inactivates some members of the Bcl-2 pro-
tein family (Harley et al., 2010; Terrano et al., 2010; Sakurikar et
al., 2012). Thus, we hypothesized whether the inhibition of ATP
synthase activity on glutamate excitotoxicity was the conse-
quence of a putative interference of cyclin B1–Cdk1 with the
interaction between Bcl-xL and -F1Fo–ATP synthase. In fact,
confocal imaging revealed that endogenous cyclin B1 and Bcl-xL
colocalized in neurons after the excitotoxic stimulus (Fig. 5A). In
good agreement with our Western blot analyses (Fig. 1A), cyclin
B1 was absent in untreated neurons as assessed by confocal mi-
croscopy (Fig. 5A). To further confirm cyclin B1 and Bcl-xL co-
localization, neurons were cotransfected with cDNA constructs
encoding either GFP (control) or cyclin B1–GFP, with Bcl-xL.
The results show that, whereas GFP showed a spread subcellular
localization, cyclin B1–GFP colocalized with Bcl-xL (Fig. 5B).
Furthermore, Bcl-xL coimmunoprecipitated with both expressed
cyclin B1 (Fig. 5C) or endogenously accumulated cyclin B1 dur-
ing glutamate treatment (Fig. 5D). Rosc, which binds to the ATP
binding site of Cdk1 catalytic domain (De Azevedo et al., 1997),
abolished such interactions (Fig. 5C, D), suggesting Bcl-xL phos-
phorylation by cyclin B1–Cdk1. To test this possibility directly,
protein extracts obtained from either HEK293T cells expressing
cyclin B1 or glutamate-treated neurons were immunoprecipi-
tated with anti-Bcl-xL, followed by anti-phospho-Ser Western
blotting. The results showed that either exogenously expressed
(Fig. 6A) or endogenously accumulated (Fig. 6B) cyclin B1 phos-
phorylated Bcl-xL, an effect that was abrogated by Rosc (Fig.
6A,B). Next, we determined whether mitochondrial cyclin B1–
Cdk1-mediated phosphorylation of Bcl-xL accounts for ATP
synthase inhibition. Bcl-xL may occur at the outer mitochondrial
membrane (Vander Heiden et al., 1997; Billen et al., 2008; Ding et
al., 2014); however, other authors have described its localization
at either the inner membrane or matrix, in which it would inter-
act with the -F1Fo–ATP synthase to regulate neuronal bioener-
getic efficiency of neurons (Alavian et al., 2011; Chen et al., 2011).
Here, we aimed to determine the submitochondrial fraction in
which cyclin B1, Bcl-xL, and-F1Fo–ATP synthase colocalized in
neurons on the excitotoxic stimulus. To do this, mitoplasts were
prepared by incubating mitochondria in hypotonic buffer (70
mM sucrose), and then proteins were analyzed by Western blot.
In good agreement with the rupture of the outer mitochondrial
membrane occurring at 70 mM sucrose, Tom20, an outer mito-
chondrial membrane protein marker, was lost (Fig. 6C). How-
ever, cyclin B1, Bcl-xL, and -F1Fo–ATP synthase proteins were
still present in these mitoplast extracts, similar to the mitochon-
drial matrix protein Hsp60 and the inner membrane protein
Ndusf1, a complex I subunit (Fig. 6C). To further corroborate the
submitochondrial localization of cyclin B1, a protease-protection
assay was performed in mitochondria isolated from glutamate-
4
(Figure legend continued.) both cyclinB1andGFP) for 4–24h.When indicated, neuronswere
treated with Rosc (10M) and GSH-EE (1 mM). Cyclin B1 expression time dependently induced
mitochondrial O2
generation in neurons, as assessedby flow cytometry. BothRosc andGSH-EE
fully prevented cyclin B1-mediatedmitochondrial O2
 generation in neurons but did notmod-
ify values in control neurons (24 h: Rosc, 11.3 0.87%; GSH-EE, 7.8 0.64).G, Neurons were
transfected and treated as inF. Expression of cyclin B1 timedependently inducedmitochondrial
depolarization in neurons. Treatments with Rosc (10 M) and GSH-EE (1 mM) abrogated
glutamate-causedm collapse in neurons. However, these treatments did notmodify values
in control neurons (24 h: Rosc, 102.3 8.49%; GSH-EE, 109.7 9.21). *p 0.05 versus
control.H, Neurons were transfected and treated as inD. Rosc (10M) partially prevented ATP
depletion causedbyglutamate. *p0.05 versus control; #p0.05 versus glutamate. InD–H,
data are the mean SEM from four independent neuronal cultures (n	 4). MW, Molecular
weight.
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Figure 4. Cyclin B1–Cdk1 activation inhibits ATP synthase, leading to oxidative damage to complex I. HEK293T cells were transfectedwith 0.8g/10 6 cells pIRES2–EGFP, either empty (Control;
expressing GFP) or containing the full-length cDNA of human cyclin B1 (Cyclin B1; expressing both cyclin B1 and GFP). A, Western blots of cell extracts were probed sequentially with antibodies to
cyclin B1, followedbyGAPDHas loading control. A representativeWesternblot is shownof three. Bar graphs represent the relative cyclin B1protein abundance comparedwith 0h (immediately after
transfection). Each bar represents themean SEM of three independent cell cultures (n	 3). *p 0.05 versus 0 h.B, Mitochondrial complex I activity wasmeasured by spectrometry at different
times after transfections. *p 0.05 versus control. C, ATP synthase activity was measured by spectrometry at different times after transfections. *p 0.05 versus control. D, HEK293T cells were
suspended inHBSS, and the rate of oxygen consumptionwasmeasured at different times after transfections byusingwith a Clark-typedissolvedoxygenelectrode. *p0.05 versus control.E,m
was assessed by flow cytometry in HEK293T at different times after transfections. *p 0.05 versus control. F, HEK293T cells were transfected with 0.8g/10 6 cells pIRES2–EGFP (control) or
pIRES2– cyclin B1–EGFP (cyclin B1) either in the absence of presence of Rosc (10M) andGSH-EE (1mM) for 24h. Cyclin B1 induced complex I oxidation, as judgedby the increase in oxidizedproteins
detected by immunoblotting from isolated biotin–NEM-labeled mitochondrial complex I subunits, which was abrogated by Rosc and GSH-EE. A representative Western blot is shown of three. Bar
graphs represent the relative band intensity comparedwith control. Each bar represents themean SEM of three independentWestern blots (n	 3). *p 0.05 versus control; #p 0.05 versus
cyclin B1.G,H, HEK293T cellswere transfected and treated as inF.Mitochondrial complex I activity (G) andATP synthase activity (H)weremeasuredby spectrometry at 24hafter transfections. *p
0.05 versus control; #p 0.05 versus cyclin B1. In B–E, G, and H, data are expressed as the mean SEM, from three or four independent cell cultures (n	 3–4). MW, Molecular weight.
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Figure 5. Cyclin B1–Cdk1 localizes tomitochondria in neurons on excitotoxic stimulus. A, Neurons were treated or not (control) with 100M glutamate for 5min andwere further incubated in
culturemedium for 12–14h. Cyclin B1 andBcl-xLwere detected by immunocytochemistry. Scale bars, 10m.Microphotograph reveals colocalization of cyclin B1withBcl-xL in neurons.B, Neurons
were cotransfected with plasmids encoding either GFP (0.8m/10 6 cells pcDNA3–GFP; control) or cyclin B1 fused with GFP (0.8m/10 6 cells pcDNA3– cyclin B1–GFP; cyclin B1–GFP) and Bcl-xL
(0.8m/10 6 cells p8–Bcl-xL) for 12–14 h. Microphotograph reveals that cyclin B1–GFP, but not GFP (control), colocalizes with Bcl-xL. Neurons were immunostained with the neuronal marker
Map2 (violet). Scale bars, 50m. C, HEK293T cells were transfected with 0.8g/10 6 cells pIRES2–EGFP, either empty (Cyclin B1) or containing the full-length cDNA of human cyclin B1 (Cyclin
B1), in either the absence or presence of Rosc (10M). At 24 h after transfections, cellular extracts were obtained and immunoprecipitated with anti-Bcl-xL antibody and analyzed byWestern blot
for cyclin B1 and Bcl-xL. Of the whole cellular extracts used for immunoprecipitation, 10% were loaded on SDS-PAGE as an input control. Coimmunoprecipitation assays revealed that cyclin B1
coprecipitated with Bcl-xL. A representativeWestern blot is shown of three. Bar graphs represent the relative band intensity compared with control. Each bar represents the mean SEM of three
independent cell cultures (n	 3). *p 0.05 versus control (Cyclin B1).D, Neurons were treated or not (Glu) with 100M glutamate for 5min andwere further incubated in culturemedium
for 20 h, in either the absence or presence of Rosc (10M). Coimmunoprecipitation assay was performed as indicated in C. Cyclin B1 coprecipitatedwith Bcl-xL in neurons on excitotoxic stimulus. A
representativeWestern blot is shown of three. Bar graphs represent the relative band intensity comparedwith control. Each bar represents themean SEMof three independent neuronal cultures
(n	 3). *p 0.05 versus untreated (Glu) neurons. MW, Molecular weight.
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treated neurons using trypsin to digest exposed proteins. As
showed in Figure 6D, similarly to Hsp60 and Ndusf1, but unlike
Tom20, cyclin B1, Bcl-xL, and -F1Fo–ATP synthase were pro-
tected from the trypsin digestion. These data demonstrate that
cyclin B1, Bcl-xL, and -F1Fo–ATP synthase colocalize in the
mitochondrial compartment, either inner membrane or matrix,
on a neuronal excitotoxic stimulus.
Next, the interaction between Bcl-xL and -F1Fo–ATP syn-
thase (ATPase) was analyzed in neurons during an excitotoxic
stress. The interaction of Bcl-xL with ATPase was disrupted by
either exogenously expressed cyclin B1 in HEK293T cells (Fig.
6E) or by endogenous cyclin B1, accumulated during excitotoxic
stress (Fig. 6F). Rosc rescued the cyclin B1–Cdk1-mediated Bcl-
xL–ATPase interaction (Fig. 6E,F). These data indicate that
glutamate-mediated cyclin B1–Cdk1 activation promotes Bcl-xL
phosphorylation, resulting in its dissociation from -F1Fo–ATP
synthase. To elucidate whether such a mechanism elicits any
functional consequence on ATP synthase activity, we performed
site-directed mutagenesis to generate Bcl-xL(D) and Bcl-xL(A)
(Abbott et al., 1986). Because Ser-62 in Bcl-xL is a high score
putative phosphorylation target of Cdk1 (Terrano et al., 2010),
we decided to mutate this residue. HEK293T cells were cotrans-
fected with cyclin B1 together with either Bcl-xL(A) or Bcl-
xL(D). We first confirmed that the phosphodefective Bcl-xL
mutant Bcl-xL(A) was not phosphorylated by cyclin B1–Cdk1
(Fig. 7A). As revealed by the coimmunoprecipitation assay,
ATPase interacted with the phosphodefective, but not with the
phosphomimetic, Bcl-xL mutant (Fig. 7B). Furthermore, the ex-
pression of the phosphodefective, but not the phosphomimetic,
Bcl-xL mutant in neurons restored the interaction of Bcl-xL with
the -F1Fo–ATP synthase on the excitotoxic stimulus (Fig. 7C).
These results demonstrate that glutamate-induced Bcl-xL phos-
phorylation at Ser42 disrupts the Bcl-xL–-subunit interaction,
hence explaining the mechanism of the previously reported inhi-
bition of ATP synthase activity (Alavian et al., 2011). In fact,
expression of the phosphodefective Bcl-xL (Fig. 7D) mutant form
exerted a dominant-negative effect, because it was unable to in-
hibit ATP synthase activity during cyclin B1 expression (Fig. 7E).
However, expression of the phosphomimetic form (Fig. 7D) im-
itated the effect of endogenous Bcl-xL at inhibiting ATP synthase
Figure 6. cyclin B1–Cdk1 phosphorylates Bcl-xL, leading to its dissociation from -F1Fo–ATP synthase on the excitotoxic stimulus. A, HEK293T cells were transfected with 0.8g/10
6 cells
pIRES2–EGFP, either empty or containing the full-length cDNA of human cyclin B1, in either the absence of presence of Rosc (10M). At 24 h after transfections, cellular extracts were obtained and
immunoprecipitated with anti-Bcl-xL antibody and analyzed by Western blot for phospho-Serine (PSer) and Bcl-xL. Expression levels of cyclin B1 (Input) is shown in Figure 5C. B, Neurons were
treated or not with 100M glutamate for 5 min and were further incubated in culture medium for 20 h. When indicated, Rosc (10M) was added to the culture medium. Neuronal extracts were
immunoprecipitated with anti-Bcl-xL antibody and analyzed by Western blot for phospho-Serine (PSer) and Bcl-xL. C, D, Neurons were exposed to glutamate as in B, and submitochondrial
localizationof cyclin B1, Bcl-xL, and-F1Fo–ATP synthasewasdetectedbymitoplasting (C) andproteaseprotection assay (D).C,Mitochondria isolated fromuntreated (Glu) or glutamate-treated
(Glu) neurons were incubated in isosmotic (320mM) or hypotonic (70mM) sucrose buffer, and extracts were subjected toWestern blot analysis with cyclin B1, Bcl-xL,-ATPase, Hsp60 (amatrix
protein), Ndusf1 (and inner membrane protein), and Tom20 (an outer membrane protein). D, Mitochondria isolated from glutamate-treated neurons were incubated in mitochondrial buffer with
or without 25 or 50 g/ml soybean trypsin. Extracts were analyzed by immunoblotting with indicated antibodies. E, HEK293T cells were transfected as described in A. Cellular extracts were
immunoprecipitatedwith anti-Bcl-xL antibodyandanalyzedbyWesternblot for-F1Fo–ATP synthase (ATPase) andBcl-xL. Of thewhole cellular extracts used for immunoprecipitation, 10%were
loaded on SDS-PAGE as an input control. Coimmunoprecipitation assays revealed that-F1Fo–ATP synthase failed to coprecipitatewith Bcl-xL in cyclin B1-transfected cells, whichwas prevented by
Rosc. F, Neuronswere exposed to glutamate as inB, and neuronal extractswere immunoprecipitated as in E. Coimmunoprecipitation assays revealed that glutamate avoided-F1Fo–ATP synthase
and Bcl-xL interaction in neurons, which was prevented by Rosc. In A, B, E, and F, a representative Western blot is shown of three. Bar graphs represent the relative band intensity compared with
Cyclin B1 (A, E) orGlu (B, F). Each bar represents themean SEMof three independent cell (A, E) or neuronal (B, F) cultures (n	 3). *p 0.05 versusCyclin B1 (A, E) orGlu (B, F). MW,
Molecular weight.
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activity (Fig. 7E). These results indicate that cyclin B1–Cdk1 me-
diated phosphorylation of Bcl-xL at Ser62, triggering its dissoci-
ation fromATPase, is sufficient to inhibit ATP synthase activity.
Finally, we aimed to elucidate whether inhibition of ATP syn-
thase activity in this manner accounted for complex I inactiva-
tion. As shown in Figure 7F, the inhibition of complex I activity
caused by cyclin B1 was abolished by coexpressing the phospho-
defective, but not the phosphomimetic, form of Bcl-xL. Thus,
ATP synthase inhibition by cyclin B1–Cdk1 is sufficient to pro-
mote complex I impairment.
Cyclin B1–Cdk1-induced Bcl-xL phosphorylation accounts
for oxidative stress andmitochondrial dysfunction on
excitotoxic stimulus
We finally sought to ascertain whether Bcl-xL phosphorylation is
essential in the signaling cascade leading to oxidative stress, m
collapse, and neuronal apoptotic death during glutamate excito-
toxicity. To do so, we used either exogenously expressed cyclin B1
or endogenously accumulated cyclin B1 during glutamate treat-
ment, both in neurons. We found that expression of the phos-
phodefective mutant form of Bcl-xL fully prevented the increase
Figure 7. Cyclin B1–Cdk1-induced Bcl-xL phosphorylation leading to its dissociation from-F1Fo–ATP synthase causes ATP synthase and complex I inhibition on the excitotoxic stimulus. A,
HEK293T cellswere cotransfectedwith 0.8g/10 6 cells pIRES2–EGFP, either empty (Control) or containing the full-length cDNAof human cyclin B1, togetherwith 0.8g/10 6 cells P8, either empty
(Control) or containing the full-length cDNA of human Bcl-xL, the phosphodefective Bcl-xL(A) or the phosphomimetic Bcl-xL(D) Ser62–Bcl-xLmutants. Cell extracts were immunoprecipitatedwith
anti-Bcl-xL antibody and analyzed by Western blot for phospho-Serine (PSer) and Bcl-xL. B, HEK293T cells were cotransfected as in B. Coimmunoprecipitation assay revealed that ATPase
coprecipitated with Bcl-xL(A) but not with Bcl-xL(D). C, Neurons were transfected with 0.8g/10 6 cells P8, either empty or containing the full-length cDNA of human phosphodefective Bcl-xL(A)
or phosphomimetic Bcl-xL(D) Ser62-Bcl-xL mutants. Neurons were then treated or not (Glu) with 100 M glutamate for 5 min and were further incubated in culture medium for 20 h.
Coimmunoprecipitation assay reveals that the Bcl-xL(A), but not the Bcl-xL(D), mutant restored the interaction of Bcl-xL with the-F1Fo–ATP synthase in neurons on the excitotoxic stimulus. InB
and C, a representativeWestern blot is shown of three. Bar graphs represent the relative band intensity compared withCyclin B1 (B) orGlu (C). Each bar represents the mean SEM of three
independent cell (B) or neuronal (C) cultures (n	 3). *p 0.05 versusCyclin B1 (B) or Glu (C). E, F, HEK293T cells were cotransfected as in B. The expression of Bcl-xL(A), but not Bcl-xL(D),
fully prevented inhibition of ATP synthase (E) and complex I (F) activities in cyclin B1-expressing cells. *p 0.05 versusCyclin B1. Data are expressed as the mean SEM of three independent
cell cultures (n	 3). MW, Molecular weight.
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in mitochondrial O2
 (Fig. 8A), m collapse (Fig. 8B), and ap-
optotic death (Fig. 8C) triggered by cyclin B1. However, these
phenomena were unaffected by expression of the phosphomi-
metic form of Bcl-xL (Fig. 8A–C). Furthermore, glutamate-
mediated increase in mitochondrial O2
 (Fig. 8D), m collapse
(Fig. 8E), and apoptotic death (Fig. 8F) were prevented by ex-
pressing the phosphodefective Bcl-xL mutant but not by its phos-
phomimetic form (Fig. 8D–F). These results indicate that Ser62
phosphorylation of Bcl-xL accounts for oxidative stress, mito-
chondrial dysfunction, and the proapoptotic effect of cyclin B1–
Cdk1 in excitotoxicity. To further confirm this, we assessed
whether Ser62 mutants affected the anti-apoptotic function of
Bcl-xL. To do so, we expressed its phosphodefective (A) mutant,
which fully prevented etoposide-induced neuronal apoptosis
(Fig. 8G). Conversely, expression of its phosphomimetic (D)
form failed to protect neurons from etoposide-mediated neuro-
toxicity. These data are in good agreement with previous findings
showing that Bcl-xL is phosphorylated at residue Ser62, hence
abolishing its anti-apoptotic function, in response to anti-mitotic
drugs in cancer cells (Schmitt et al., 2007; Upreti et al., 2008;
Antony et al., 2010).
Discussion
We have shown previously that an excitotoxic challenge by over-
activation of NMDA receptors triggers the stabilization of cyclin
B1 because of a cascade of events involving Ca 2-mediated acti-
vation of calpain to breakdown p35 into p25, which strongly
activated Cdk5 activity in the nucleus (Maestre et al., 2008). Ac-
tive Cdk5 hyperphosphorylated Cdh1, leading to its dissociation
from APC/C, which causes the inhibition of Cdh1 ability to co-
activate APC/C (Jaquenoud et al., 2002; Maestre et al., 2008).
Here, we now demonstrate that the stabilization of cyclin B1 after
this excitotoxic challenge occurs selectively in mitochondria. In a
previous work, forced expression of a mutant form of cyclin B1
harboring a mitochondrial leading sequence in dividing cells ex-
erted the coordination of the mitochondrial respiration with cell-
cycle progression, especially the G2/M transition (Wang et al.,
2014). However, recruitment of endogenous cyclin B1, as we
herein show, has not been reported so far. This result is intrigu-
ing, because naive cyclin B1 apparently lacks a mitochondrial
leading sequence. In addition, postmitotic neurons do not need
to exert this coordination (Wang et al., 2014), which is an exclu-
Figure8. CyclinB1–Cdk1-inducedBcl-xLphosphorylation accounts for oxidative stress andmitochondrial dysfunctionon theexcitotoxic stimulus.A–C, Neurons cellswere cotransfectedwith0.8
g/10 6 cells pIRES2–EGFP, either empty (Control) or containing the full-length cDNA of human cyclin B1, together with 0.8g/10 6 cells P8, either empty (Control) or containing the full-length
cDNA of human phosphodefective Bcl-xL(A) or phosphomimetic, Bcl-xL(D) Ser62-Bcl-xL mutants. Mitochondrial O2
 generation (A), mitochondrial membrane potential (m) (B), and neuronal
apoptotic death (annexin V/7-AAD neurons) (C) were assayed by flow cytometry in transfected (GFP) neurons. The expression of Bcl-xL(A), but not Bcl-xL(D), prevented cyclin B1-induced
oxidative stress (A), m loss (B), and apoptosis (C) in neurons. *p 0.05 versusCyclin B1 (control). D–F, Neurons were transfected with 0.8 g/10 6 cells P8, either empty (control) or
containing human phosphodefective Bcl-xL(A) or phosphomimetic Bcl-xL(D) Ser62–Bcl-xL mutants. Neurons were then treated or not (Glu) with 100M glutamate for 5 min and were further
incubated in culturemedium for 20h. Theexpressionof Bcl-xL(A), but notBcl-xL(D), preventedglutamate-inducedoxidative stress (D),mloss (E), andapoptosis (F) in neurons. *p0.05 versus
Glu (control); #p 0.05 versus glutamate. G, Neurons were transfected as in D and then were exposed to etoposide (10M) for 24 h. The expression of Bcl-xL(A), but not Bcl-xL(D), prevented
glutamate-induced neuronal apoptosis. *p 0.05 versusEtoposide (control). In all cases, data are expressed as the mean SEM of three or four independent neuronal cultures (n	 3–4).
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sive function of proliferating cells. Thus, the mechanism whereby
cyclin B1 specifically recruits to mitochondria and the conse-
quence(s) of such a subcellular localization remain unknown.
We show that Cdk1 is responsible for the recruitment of cyclin
B1 to mitochondria, because both proteins colocalize in the or-
ganelle. Furthermore, because we found that Bcl-xL phosphory-
lated at Ser62, i.e., its Cdk1-cognate phosphorylating residue
(Terrano et al., 2010), the formation of a cyclin B1–Cdk1 com-
plex in mitochondria is highly likely. In good agreement with
previous studies performed in cancer cells (Schmitt et al., 2007;
Upreti et al., 2008; Antony et al., 2010), phosphorylation at Ser62
lost the anti-apoptotic activity of Bcl-xL in neurons, suggesting its
involvement in mitochondrial dysfunction during glutamate
treatment. However, because its phosphomimetic form failed to
affect mitochondrial membrane potential and oxidative stress,
additional mechanisms cannot be disregarded. Bcl-xL is known
to interact with the subunit of the F1Fo–ATP synthase to form a
stable complex and maximize the efficiency of production of ATP
(Alavian et al., 2011). Here, we show that phosphorylation of
Ser62 in Bcl-xL is sufficient to promote its dissociation from the
subunit of the F1Fo–ATP synthase, leading to inhibition of ATP
synthase enzymatic activity. Inhibition of ATP synthase activity is
known to affect the m (Brand et al., 2004; Sa´nchez-Cenizo et
al., 2010; Formentini et al., 2014). In fact, in our hands, glutamate
exerted a cyclin B1-mediated biphasic effect on m, namely a
transient increase followed by a delayed collapse. During the in-
creasedm phase, the mitochondrial respiratory chain is known
to stimulate O2
 (Sa´nchez-Cenizo et al., 2010; Formentini et al.,
2014), which we found in neurons on the excitotoxic stimulus.
Mitochondrial complex I contains O2
-sensitive Fe-S clusters
(Sazanov, 2014) and specific cysteine residues (Chouchani et al.,
2013) that are essential for optimal electron transfer toward
ubiquinone. Accordingly, an increased production of O2
, by
either complex I or complex III (Murphy, 2009), caused both
delayed oxidative damage to complex I and impairment in the
electron transfer likely responsible for the inhibition of its activ-
ity. This effect had functional consequences for the intact cell,
because both m was lost in a delayed manner, and the rate of
O2 consumption was impaired dramatically.
The delayed collapse inm observed under our conditions is
likely attributable to the inefficacy of complex I at pumping pro-
tons into the intermembrane space, a trigger of the mitochondrial
transition pore. It has been shown recently that this pore is
formed by dimerization of F1Fo–ATP synthase  subunits (Car-
raro et al., 2014). Thus, dissociation of phosphorylated Bcl-xL
from the F1Fo–ATP synthase  subunits that we herein describe
might be an important step in this process by allowing free F1Fo–
ATP synthase  subunits to dimerize. Subsequent opening of the
mitochondrial transition pore will initiate mitochondrial outer
membrane permeabilization to promote the release of proapop-
totic factors (Galluzzi et al., 2009; Bernardi, 2013), shown previ-
ously to be sensitive to Bcl-xL binding to the F1Fo–ATP synthase
 subunit (Chen et al., 2011; Alavian et al., 2014).
In conclusion, here we decipher a cascade of events triggered
by the overactivation of glutamate receptors in neurons, an un-
derlying feature of several neurological diseases. This transduc-
tion pathway requires mitochondrial cyclin B1 to activate Cdk1
to promote phosphorylation of anti-apoptotic Bcl-xL. Phosphor-
ylated Bcl-xL releases the  subunit of F1Fo–ATP synthase, likely
forming the transition pore that promotes apoptosis. This mech-
anism can account for the known deleterious effects of cyclin B1
accumulation in the degenerating brain areas of neurological dis-
eases (Vincent et al., 1997; Love, 2003; Yang et al., 2003). Further-
more, the negative regulation of mitochondrial function by
cyclin B1–Cdk1 activity that we describe here may have implica-
tions beyond the neural tissue. For instance, it is known that
cancer cells upregulate aerobic glycolytic metabolism to support
aberrant cell proliferation (Vander Heiden et al., 2009), which is
coupled with decreased APC/C–Cdh1 activity (Almeida et al.,
2010; Moncada et al., 2012). The aberrantly accumulated cyclin
B1 in mitochondria causing inhibition of complex I impairs the
energetic efficiency of mitochondria, and this would likely stim-
ulate glycolysis in proliferating cells. The combination of such a
metabolic switch with the abnormal ability of cancer cells to form
the transition pore (Brenner and Grimm, 2006; Javadov et al.,
2011) would represent a previously unrecognized mechanism
whereby cyclin B1–Cdk1 promotes cancer cell progression.
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